Clinical Trial Update: A Phase 1/2 Study of BA3071 in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of BA3071 in patients with solid tumors, including non-small cell lung cancer and melanoma, currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• BA3071

Snippet

Sponsor: BioAtla, Inc. | Conditions: NSCLC, Melanoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING